Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

CSL Limited (CSL)

Index:

ASX 100

Add To Portfolio

NULL

52 Week High: NULL
52 Week Low: $209.25

Currency: Australian Dollars
Shares Issued: 453.10m

CSL Limited Overview

CSL is a global biopharmaceutical company that develops, construct and promotes products to treat and prevent medical conditions. The group operating in 27 countries worldwide produce various blood plasma, cell reagents, antivenom and other vaccines through their protein based biotherapies.

3 Month Chart

1 Year Chart

More CSL Limited charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	0.0%
Div Cover	2.3
Op Mrgn	27.4%
ROCE	31.6%

	Latest	F'cast
P/E	n/a
PEG	n/a
Pr/Revenue	n/a
Pr/Book	n/a

	Latest	F'cast
Revenue	5.9%
PBT	1.6%
EPS	8.8%
DPS	3.8%

CSL Limited Fundamentals

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
30-Jun-08	3,556.66	952.02	127.58¢	n/a	n/a	+30%	46.00¢	0.0%
30-Jun-09	4,622.39	1,369.75	192.51¢	n/a	n/a	+51%	70.00¢	0.0%
30-Jun-10	4,455.82	1,379.45	185.77¢	n/a	n/a	-4%	80.00¢	0.0%
30-Jun-11	4,187.60	1,198.10	174.01¢	n/a	n/a	-6%	80.00¢	0.0%
30-Jun-12	4,433.20	1,216.80	189.24¢	n/a	n/a	+9%	83.00¢	0.0%

CSL Limited Forecasts

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
30-Jun-26	16,249.50	4,834.68	606.65¢	n/a	n/a	+221%	259.59¢	0.0%
30-Jun-27	17,167.69	5,417.77	691.06¢	n/a	n/a	+14%	295.46¢	0.0%
30-Jun-28	18,203.22	6,013.91	779.79¢	n/a	n/a	+13%	338.25¢	0.0%